4.7 Article

Recovery of Hippocampal Network Connectivity Correlates with Cognitive Improvement in Mild Alzheimer's Disease Patients Treated with Donepezil Assessed by Resting-State fMRI

期刊

JOURNAL OF MAGNETIC RESONANCE IMAGING
卷 34, 期 4, 页码 764-773

出版社

WILEY-BLACKWELL
DOI: 10.1002/jmri.22662

关键词

resting-state functional MRI; hippocampus; Alzheimer's disease; donepezil

资金

  1. Eisai Inc.
  2. Pfizer Inc.
  3. NIH-NIA [AD 20279]
  4. NIH [2R01AG020279-06A2, 2R01DA010214-11A1, R01 AG20279]
  5. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  6. Extendicare Foundation
  7. Advancing Healthier Wisconsin Endowment for Research
  8. NHLBI, NIH Women's Health Initiative [N01-WH 44221]
  9. China Scholarship Council [CSC20070320]
  10. Bristol Myers Squibb
  11. Danone
  12. Elan
  13. Genentech
  14. Octapharma AG
  15. General Clinical Research Center [M01 RR00058]
  16. DANA Foundation

向作者/读者索取更多资源

Purpose: To identify the neural correlates of cognitive improvement in mild Alzheimer's disease (AD) subjects following 12 weeks of donepezil treatment. Materials and Methods: Resting-state functional connectivity magnetic resonance imaging (R-fMRI) was used to measure the hippocampal functional connectivity (HFC) in 14 mild AD and 18 age-matched normal (CN) subjects. AD subjects were scanned at baseline and after donepezil treatment. CN subjects were scanned only at baseline as a reference to identify regions correlated or anticorrelated to the hippocampus. Before each scan, participants underwent cognitive, behavioral, and functional assessments. Results: After donepezil treatment, neural correlates of cognitive improvement measured by Mini-Mental State Examination scores were identified in the left parahippocampus, dorsolateral prefrontal cortex (DLPFC), and inferior frontal gyrus. Improvement in AD Assessment Scale-cognitive subscale scores correlated with the HFC changes in the left DLPFC and middle frontal gyrus. Stronger recovery in the network connectivity was associated with cognitive improvement. Conclusion: R-fMRI may provide novel insights into the brain's responses to AD treatment in clinical pharmacological trials, and also may predict clinical response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据